"Another politician might find questions, such as the Pizzagate questions, amusing or they might welcome the distraction. She ...
The evidence is solid but not definitive, as the conclusions rely on the absence of changes in spatial breadth and would benefit from clearer statistical justification and a more cautious ...
Wearable health technology is rapidly evolving from passive tracking to active physiological modulation. What began with step ...
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the FCE870Q Wi-Fi7 and Bluetooth 6.0 ...
High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease and stroke. For decades, researchers have observed that premenopausal women ...
Barcelona, Rohde & Schwarz and Qualcomm Technologies will present a live demonstration at the Rohde & Schwarz booth (5A80) ...
T cells are highly adaptable white blood cells that protect us from infections, cancer, and other threats. To do their job, T cells must rapidly switch from a quiet resting state to an active, energy ...
Next steps have been taken to advance the implementation of California’s highly anticipated Responsible Textile Recovery Act, ...
U.S. scientists have discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, ...
The Spectrum Management Authority (SMA) has warned about the risks associated with signal interference and the shared responsibility of entities which use the spectrum to ensure safe airspace ...
For Patients With mCRPC, Results With Pluvicto in Real-World Settings Keep Pace With Clinical Trials
Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results